• Skip to primary navigation
  • Skip to main content
  • Skip to footer
  • English
MotherToBaby

MotherToBaby

Medications and More during pregnancy and breastfeeding

Hide Search
Show Search
866.626.6847
  • About
    • Our Work
    • Our Team
    • Our Partners
  • Exposures
    • Pregnancy & Breastfeeding Exposures
    • Fact Sheets
    • Baby Blogs
    • Podcasts
  • Studies
    • Ongoing Studies
    • Pregnant Women
    • Join Now
    • Health Providers
    • Pharma Industry
    • Publications
  • Health Professionals
    • Patient Education and Provider Resources
    • Refer a Patient
    • Request Materials
    • Meetings
    • FAQs
    • OTIS Membership
  • Media
    • Press Releases
    • Media Requests
  • In Your Area
  • OTIS
    • About OTIS
    • OTIS Membership
    • Annual Meeting
    • Member Log-In
    • Donate
  • Contact

Dermatology

Treating Pregnant and Lactating Patients with Dermatologic Conditions

MotherToBaby supports dermatologists in managing skin conditions during a patient’s reproductive years. We understand the challenges that you face when deciding on treatment courses when your patient is pregnant or breastfeeding. Whether tending to a patient with a pre-existing illness like psoriasis or atopic dermatitis, or a pregnancy dermatosis like PUPPP, our resources will help you weigh the risks and benefits to both mom and baby as you determine a treatment plan that maximizes disease management and minimizes maternal and fetal/infant risk. 

We are also dedicated to furthering the information and understanding of medication safety in pregnancy through our observational MotherToBaby Pregnancy Studies. We are proud to lead more than half of all Food and Drug Administration (FDA)-mandated pregnancy registries conducted in the U.S., including studies on psoriasis and atopic dermatitis treatments. MotherToBaby Pregnancy Studies are rigorously designed cohort studies that aim to provide critically needed product safety information – and your patient referrals make all the difference. With your referral, you are helping us generate data that will lead to improved product safety information in pregnancy, thereby providing you and your patients with the evidence you need to make more informed treatment decisions.

Dermatologists are frequently faced with questions about the safety of commonly prescribed topical and systemic medications during pregnancy and lactation from women of childbearing age who are pregnant, considering pregnancy, or breastfeeding. Safety data, particularly regarding medications that are unique to dermatology, can be difficult to locate and are not consolidated in a single reference guide for clinicians.

— Murase et al. J Am Acad Dermatol. 2014;70(3):401.e1-415.

Explore how we can help you and your pregnant and breastfeeding patients by providing no-cost exposure risk assessments, patient education materials, observational studies to monitor pregnancy outcomes, and more.

Related Studies

  • Cimzia® (certolizumab pegol)
  • Coronavirus (COVID-19)
  • Dupixent® (dupilumab)‎
  • Eczema (Moderate-to-Severe)/Atopic Dermatitis
  • Ilumya™ (tildrakizumab-asmn)
  • Otezla® (apremilast)
  • Psoriasis
  • Psoriatic Arthritis
  • Tremfya® (guselkumab)

Related Fact Sheets

  • Adalimumab (Humira®)
  • Apremilast (Otezla®)
  • Azathioprine | 6-mercaptopurine
  • Certolizumab Pegol (Cimzia®)
  • Dupilumab (Dupixent®)
  • Etanercept (Enbrel®)
  • Guselkumab (Tremfya®)
  • Infliximab (Remicade®)
  • Isotretinoin (Accutane®)
  • Methotrexate
  • Prednisone | Prednisolone
  • Psoriasis and Psoriatic Arthritis
  • Staphylococcus aureus (Staph Infection)
  • Tildrakizumab (Ilumya™)
  • Topical Acne Treatments
  • Topical Corticosteroids
  • Tretinoin (Retin-A®)
  • Ustekinumab (Stelara®)

Exposure Information

We provide no-cost, evidence-based info on exposures during pregnancy or breastfeeding by phone, text, email, and chat.

Contact

Request Materials

We offer free patient education materials and provider resources for our information service and pregnancy studies.

ORDER

Partners

  • Society for Maternal-Fetal Medicine
  • Society for Birth Defects Research & Prevention
  • Patient Education Genius
  • MyHealthTeams
  • PatientsLikeMe
  • The Mighty

FAQs

Get answers to the most frequently asked questions about our information service and pregnancy studies.

Read

Stay In Touch

Our e-Newsletter brings you the latest information, news, and resources from the experts at MotherToBaby.

Sign Up

Refer a Patient

Need to give your patient a personalized assessment on an exposure risk or connect her to our pregnancy studies?

refer

Footer

           

Hot Links

  • Home
  • Exposures
  • Fact Sheets
  • Baby Blogs
  • Podcasts
  • Pregnancy Studies
  • Join a Study Now
  • Healthcare Professionals
  • Refer a Patient
  • Request Materials
  • News
  • Donate
  • Ask An Expert

Current Studies

  • Ankylosing Spondylitis
  • Asthma
  • Coronavirus (COVID-19)
  • Crohn’s Disease
  • Eczema (Moderate-to-Severe)/Atopic Dermatitis
  • Juvenile Idiopathic Arthritis
  • Multiple Sclerosis
  • Pertussis/Tdap vaccine (“Whopping Cough” vaccine)
  • Psoriasis
  • Psoriatic Arthritis
  • Rheumatoid Arthritis
  • Ulcerative Colitis

Contact

Exposure Information Service
866.626.6847

Pregnancy Studies
877.311.8972

Media Inquiries
619.368.3259
nchavez@mothertobaby.org

MotherToBaby, a service of the Organization of Teratology Information Specialists
OTIS Logo

OTIS National Office
5034A Thoroughbred Lane
Brentwood, TN 37027

Copyright © 2021 The Organization of Teratology Information Specialists

  • Accessibility
  • Privacy
  • Terms
  • Site Map
^